Lei Clifton

The paper introduces MedMisBench, a benchmark to measure LLMs' ability to maintain correct medical judgment under misleading context, showing significant drops in accuracy when exposed to adversarial inputs.

The paper identifies early plasma proteomic changes preceding amyloidosis diagnosis, showing cardiac and immune dysregulation before clinical symptoms.

The paper compares two polygenic risk scores for breast cancer, hypertension, and dementia in the UK Biobank, finding substantial discordance in individual risk predictions despite similar overall performance.